Cargando…
THU554 Unconventional Estrogen Receptor Antagonists Reveal Cryptic Therapeutic Anti-breast Cancer Transcriptional Pathways
Disclosure: G. Hancock: None. K. Young: None. G.L. Greene: None. S.W. Fanning: Advisory Board Member; Self; Olema Oncology. Grant Recipient; Self; Olema Oncology. Breast cancer is the most diagnosed cancer and 2nd leading cause of cancer-related death in women worldwide. The luminal subtype accounts...
Autores principales: | Hancock, Govinda, Young, Kristen, Greene, Geoffrey L, Fanning, Sean William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554243/ http://dx.doi.org/10.1210/jendso/bvad114.2180 |
Ejemplares similares
-
THU546 A Lasofoxifene/Elacestrant Hybrid Antiestrogen Shows Effective Anti-tumoral Activities In Y537S ESR1 Breast Cancer Xenografts
por: Young, Kristen S, et al.
Publicado: (2023) -
THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023) -
THU545 Growth Hormone Receptor Antagonist As A Novel Combination Therapy Against Triple Negative Breast Cancer
por: Mora-Criollo, Patricia, et al.
Publicado: (2023) -
THU491 GRHL2 Overexpression In Breast Cancer Progression
por: Zheng, Christy, et al.
Publicado: (2023) -
THU516 An Unusual Neck Mass
por: Rios, Paola, et al.
Publicado: (2023)